2026-01-18 - Analysis Report
**AbbVie Inc (ABBV) Financial Report**
======================================

**Company Overview**
-------------------

AbbVie Inc is a global biopharmaceutical company developing and commercializing a diverse range of medicines to help patients.

**Comparison of Return Rates**
-----------------------------

|   | Review Stock | Comparison Stock (VOO) |
|---|---------------|-------------------------|
| Cumulative Return | 175.47% | 93.36% |
| **Divergence** | N/A | N/A |

**Alpha, Beta Analysis**
-----------------------

|   | 2016-2018 | 2017-2019 | 2018-2020 | 2019-2021 | 2020-2022 | 2021-2023 | 2022-2024 | 2023-2025 |
|---|-----------|-----------|-----------|-----------|-----------|-----------|-----------|-----------|
| CAGR | 50.0% | 42.0% | 4.0% | 61.0% | 66.0% | 45.0% | 37.0% | 99.0% |
| MDD | 16.0% | 21.6% | 21.6% | 20.5% | 18.5% | 18.5% | 18.9% | 18.9% |
| Alpha | 46.0% | 25.0% | -17.0% | 18.0% | 68.0% | 44.0% | 18.0% | 37.0% |
| Beta | 1.0 | 1.1 | 0.8 | 0.7 | 0.6 | 0.4 | 0.3 | 0.3 |

**Stock Price Fluctuations**
---------------------------

|   |  Close  | 5-day SMA  | 20-day SMA  | 60-day SMA  |
|---|---------|-------------|--------------|--------------|
|   | $214.35 | $218.76 | $225.01 | $225.80 |

**RSI, PPO, Market Risk Indicator**
--------------------------------

|   | RSI | PPO | MRI |
|---|-----|-----|-----|
|   | 34.11 | -0.56 | 0.80 |

**Recent News & Significant Events**
----------------------------------

* AbbVie (ABBV) Stock Dips While Market Gains: Key Facts
* AbbVie (ABBV) Stock Falls Amid Market Uptick: What Investors Need to Know
* AbbVie Call Options Spike 2,599%: Tracking the Big Bet
* Assessing AbbVie (ABBV) Valuation After Recent Share Price Weakness
* AbbVie: Rocky Near-Term, Positive Long-Term (NYSE:ABBV)
* What Can Trigger A Breakout In Abbvie Stock?

**Analyst Opinions**
--------------------

* Analyst Consensus:
	+ Key: Buy
	+ Mean (1=StrongBuy~5=Sell): 1.93 (~Buy)
	+ Opinions: 27
	+ Target Price (avg/high/low): 245.04 / 289.00 / 184.00

**Comprehensive Analysis**
-------------------------

AbbVie Inc (ABBV) has shown a significant return rate of 175.47% compared to the comparison stock VOO's 93.36%. The company's recent stock price fluctuations indicate a decline with a close price of $214.35 and a 5-day SMA of $218.76.

The RSI and PPO indicators suggest a bearish trend, with an RSI of 34.11 and a PPO of -0.56. The Market Risk Indicator (MRI) is at 0.80, which suggests a medium investment risk level.

Recent news and significant events indicate a dip in the stock's price while the market gains, as well as a spike in call options. Analyst opinions suggest a buy recommendation with a mean rating of 1.93 and a target price of $245.04.

Overall, AbbVie Inc (ABBV) presents a mixed picture, with a high return rate compared to the comparison stock but a bearish trend in RSI and PPO indicators.

**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.